Contributions
The MACR routinely contributes data to the following studies:
In addition to contributing data for the matching programs, the MACR has performed matches working directly with the researcher. Some of these matches include:
- The World Trade Center Health Registry for researchers investigating the link between exposure to 9/11 debris and cancer
- The Society for Assisted Reproductive Technology (SART) for various researchers investigating the link between artificial reproductive technology and cancer in children and parents
- An Objective Assessment of Financial Burden Associated with Thyroid Cancer for researchers involving the links between credit score and cancer diagnosis
- Breast Cancer AI Risk Assessment Model Across Diverse Patient Populations
- Simulating the impact of an intervention to increase neighborhood greenness on the racial disparity in prostate mortality in Massachusetts
- Determining cancer incidence and mortality for incarcerated patients compared to the general population for patients in Massachusetts and North Carolina
Publications
Bolded text indicates the MACR staff member(s) responsible for authoring or co-authoring the publication.
2025:
Outpatient palliative care and end-of-life care intensity: linking Massachusetts Cancer Registry with All-Payer Claims Database. Keating NL, Weissman JS, Wright AA, Wolf R, Gershman S, Knowlton R, Ayanian JZ.JNCI Cancer Spectr. 2025 Jan 3;9(1):pkaf010. doi: 10.1093/jncics/pkaf010.PMID: 39847541
2024:
Reporting tumor genomic test results to SEER registries via linkages. Petkov VI, Byun JS, Ward KC, Schussler NC, Archer NP, Bentler S, Doherty JA, Durbin EB, Gershman ST, Cheng I, Insaf T, Gonsalves L, Hernandez BY, Koch L, Liu L, Monnereau A, Morawski BM, Schwartz SM, Stroup A, Wiggins C, Wu XC, Bonds S, Negoita S, Penberthy L.J Natl Cancer Inst Monogr. 2024 Aug 1;2024(65):168-179. doi: 10.1093/jncimonographs/lgae013.PMID: 39102888
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake. Mukand NH, Chirikova E, Lichtensztajn D, Negoita S, Aboushwareb T, Bennett J, Brooks JD, Leppert JT, Chung BI, Li C, Schwartz SM, Gershman ST, Insaf T, Morawski BM, Stroup A, Wu XC, Doherty JA, Petkov VI, Zambon JP, Gomez SL, Cheng I. Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake. Cancer. 2024 Dec 15;130(24):4298-4305. doi: 10.1002/cncr.35511. Epub 2024 Aug 19. PMID: 39158464.
2023:
Use of the Decipher genomic classifier among men with prostate cancer in the United States. Zaorsky NG, Proudfoot JA, Jia AY, Zuhour R, Vince R Jr, Liu Y, Zhao X, Hu J, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gershman S, Cheng I, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura M, Schwartz SM, Ward KC, Wiggins C, Wu XC, Shoag JE, Ponsky L, Dal Pra A, Schaeffer EM, Ross AE, Sun Y, Davicioni E, Petkov V, Spratt DE.JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad052. doi: 10.1093/jncics/pkad052.PMID: 37525535
Advancing Social and Environmental Research in Cancer Registries Using Geomasking for Address-Level Data. Iyer HS, Shi X, Satagopan JM, Cheng I, Roscoe C, McLaughlin RH, Stroup AM, Setoguchi S, Bandera EV, Hernandez BY, Doherty JA, Hsieh MC, Knowlton R, Qin B, Laden F, Rebbeck TR, Gomez SL.Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1485-1489. doi: 10.1158/1055-9965.EPI-23-0790.PMID: 37908192
2022:
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, Saint-Jacques N, Minicozzi P, De P, Rodríguez-Barranco M, Larønningen S, Di Carlo V, Mägi M, Valkov M, Seppä K, Wyn Huws D, Coleman MP, Allemani C; CONCORD Working Group*.Lancet Child Adolesc Health. 2022 Jun;6(6):409-431. doi: 10.1016/S2352-4642(22)00095-5. Epub 2022 Apr 22.PMID: 35468327 (*-the MCR is part of the CONCORD Working Group)
The risks of birth defects and childhood cancer with conception by assisted reproductive technology. Luke B, Brown MB, Wantman E, Schymura MJ, Browne ML, Fisher SC, Forestieri NE, Rao C, Nichols HB, Yazdy MM, Gershman ST, Sacha CR, Williams M, Ethen MK, Canfield MA, Doody KJ, Eisenberg ML, Baker VL, Williams C, Sutcliffe AG, Richard MA, Lupo PJ.Hum Reprod. 2022 Oct 31;37(11):2672-2689. doi: 10.1093/humrep/deac196.PMID: 36112004
History of cancer and fertility treatment outcomes: a registry linkage study in Massachusetts. Farland LV, Stern JE, Hwang SS, Liu CL, Cabral H, Knowlton R, Gershman ST, Coddington CC 3rd, Missmer SA.J Assist Reprod Genet. 2022 Feb;39(2):517-526. doi: 10.1007/s10815-021-02376-x. Epub 2022 Jan 17.PMID: 35037166
BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010-2013: An observational study using state cancer registry and All-Payer claims data. Pace LE, Ayanian JZ, Wolf RE, Knowlton R, Gershman ST, Hawkins SS, Keating NL.Cancer Med. 2022 Jul;11(13):2679-2686. doi: 10.1002/cam4.4648. Epub 2022 Mar 21.PMID: 35312162
Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study. Haas CB, Engels EA, Horner MJ, Freedman ND, Luo Q, Gershman S, Qiao B, Pfeiffer RM, Shiels MS.Lancet HIV. 2022 Oct;9(10):e700-e708. doi: 10.1016/S2352-3018(22)00219-3.PMID: 36179753
Using community-engaged methods to develop a study protocol for a cost analysis of a multi-site patient navigation intervention for breast cancer care. Rajabiun S, Xiao V, Bak S, Robbins C, Casanova N, Cabral HJ, Lemon SC, Haas JS, Freund KM, Battaglia T; TRIP Consortium.BMC Health Serv Res. 2022 Jul 8;22(1):881. doi: 10.1186/s12913-022-08192-y.PMID: 35804359
2021:
Racial differences in the treatment and outcomes for prostate cancer in Massachusetts. Cole AP, Herzog P, Iyer HS, Marchese M, Mahal BA, Lipsitz SR, Nyambose J, Gershman ST, Kennedy M, Merriam G, Rebbeck TR, Trinh QD.Cancer. 2021 Aug 1;127(15):2714-2723. doi: 10.1002/cncr.33564. Epub 2021 May 17.PMID: 33999405
Early-life cancer, infertility, and risk of adverse pregnancy outcomes: a registry linkage study in Massachusetts. Farland LV, Stern JE, Hwang SS, Liu CL, Cabral H, Knowlton R, Gershman ST, Coddington CC 3rd, Missmer SA.Cancer Causes Control. 2021 Feb;32(2):169-180. doi: 10.1007/s10552-020-01371-4. Epub 2020 Nov 27.PMID: 33247354
Smoking cessation potential among newly diagnosed cancer patients: a population-based study of the ten most common cancers in Massachusetts, USA, 2008-2013. Stang A, Knowlton R, Rekowski J, Gershman ST, Galea S.Ann Epidemiol. 2021 Apr;56:55-60.e11. doi: 10.1016/j.annepidem.2020.11.004. Epub 2020 Nov 12.PMID: 33189878
2020:
Assessment of Birth Defects and Cancer Risk in Children Conceived via In Vitro Fertilization in the US. Luke B, Brown MB, Nichols HB, Schymura MJ, Browne ML, Fisher SC, Forestieri NE, Rao C, Yazdy MM, Gershman ST, Ethen MK, Canfield MA, Williams M, Wantman E, Oehninger S, Doody KJ, Eisenberg ML, Baker VL, Lupo PJ.JAMA Netw Open. 2020 Oct 1;3(10):e2022927. doi: 10.1001/jamanetworkopen.2020.22927.PMID: 33119107
Tobacco-Associated Cancer Incidence and Mortality in Massachusetts, 2006-2015. Knowlton R, Gershman ST, MacMillan A.J Registry Manag. 2020 Summer;47(2):48-59.PMID: 35363671
Cancer Incidence in Older Adults in the United States: Characteristics, Specificity, and Completeness of the Data. Weir HK, Sherman R, Yu M, Gershman S, Hofer BM, Wu M, Green D.J Registry Manag. 2020 Fall;47(3):150-160.PMID: 33584972
Cancer Incidence Rate Variations among the Chinese, South Asian, and Vietnamese in Massachusetts, 2011-2015. Knowlton R, Gershman ST, MacMillan A.J Registry Manag. 2020 Fall;47(3):118-121.PMID: 34128917
2018:
Cancers Among the Oldest Old in Massachusetts from 2004-2014. Cook E, Gershman S, Knowlton R.J Registry Manag. 2018 Spring;45(1):21-27.PMID: 30183693
Cancer Among Adolescents and Young Adults in Massachusetts from 2004 to 2014. Cook EE, MacMillan A, Gershman ST.J Adolesc Young Adult Oncol. 2018 Aug;7(4):493-498. doi: 10.1089/jayao.2018.0005. Epub 2018 Mar 22.PMID: 29565711
Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer. Cook EE, Gershman ST, Kim JJ, Tamimi RM, Klevens RM, Holmes MD.Cancer Causes Control. 2018 May;29(4-5):435-443. doi: 10.1007/s10552-018-1016-1. Epub 2018 Mar 1.PMID: 29497883
Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women. Feldman S, Cook E, Davis M, Gershman ST, Hanchate A, Haas JS, Perkins RB.J Low Genit Tract Dis. 2018 Oct;22(4):314-317. doi: 10.1097/LGT.0000000000000435.PMID: 30256336
2017:
An Assessment of the Primary Payer Variable among Breast and Colorectal Cancer Cases in the Massachusetts Cancer Registry, 2005-2009. Gershman S, Weiss N, Knowlton R, Solis A, Das B. J Registry Manag. 2017 Winter;44(4):143-145. PMID: 30133430.
Previous:
An assessment of the reliability of race, Hispanic ethnicity, birthplace, and tobacco history data in the Massachusetts cancer registry, 2005-2009.Knowlton R, Gershman S, Solis A, Das B.J Registry Manag. 2014 Fall;41(3):146-50.PMID: 25419609
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group. Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.PMID: 25467588
Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010. Stang A, Hawk H, Knowlton R, Gershman ST, Kuss O.Ann Epidemiol. 2014 Nov;24(11):849-54. doi: 10.1016/j.annepidem.2014.07.018. Epub 2014 Aug 23.PMID: 25241148
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3). Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C; CONCORD Working Group.Neuro Oncol. 2023 Mar 14;25(3):580-592. doi: 10.1093/neuonc/noac217.PMID: 36355361
Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3). Girardi F, Di Carlo V, Stiller C, Gatta G, Woods RR, Visser O, Lacour B, Tucker TC, Coleman MP, Allemani C; CONCORD Working Group.Neuro Oncol. 2023 Mar 14;25(3):593-606. doi: 10.1093/neuonc/noac232.PMID: 36215122
Featured Partner Publications
The MACR contributed data to the researchers who authored these publications.
Debt, Bankruptcy, and Credit Scores After Cancer Diagnosis. Uppal N, Gomez-Mayorga JL, O'Donoghue AL, Fleishman A, Bogdanovski AK, Roth EM, Broekhuis JM, Hu-Bianco QL, Esselen KM, James BC. JAMA Oncol. 2025 Aug 28:e253302. doi: 10.1001/jamaoncol.2025.3302. Epub ahead of print. PMID: 40875239; PMCID: PMC12395357.
Breast Cancer Treatment Following Health Reform: Evidence From Massachusetts. Sabik LM, Eom KY, Dahman B, Li J, van Londen GJ, Bradley CJ. Med Care Res Rev. 2022 Jun;79(3):371-381. doi: 10.1177/10775587211042532. Epub 2021 Sep 1. PMID: 34467806; PMCID: PMC11460560.
Breast Cancer Incidence, Hormone Receptor Status, Historical Redlining, and Current Neighborhood Characteristics in Massachusetts, 2005-2015. Wright E, Waterman PD, Testa C, Chen JT, Krieger N. JNCI Cancer Spectr. 2022 Mar 2;6(2):pkac016. doi: 10.1093/jncics/pkac016. PMID: 35603845; PMCID: PMC8953461.
The Impact of Massachusetts Health Reform on Colorectal and Breast Cancer Stage at Diagnosis. Sabik LM, Eom KY, Dahman B, Li J, Yao N, van Londen GJ, Bradley CJ. Med Care. 2020 Feb;58(2):183-191. doi: 10.1097/MLR.0000000000001241. PMID: 31934958; PMCID: PMC6964255.
Cancer Stage at Diagnosis, Historical Redlining, and Current Neighborhood Characteristics: Breast, Cervical, Lung, and Colorectal Cancers, Massachusetts, 2001-2015. Krieger N, Wright E, Chen JT, Waterman PD, Huntley ER, Arcaya M. Am J Epidemiol. 2020 Oct 1;189(10):1065-1075. doi: 10.1093/aje/kwaa045. PMID: 32219369; PMCID: PMC7666416.
Cancer Incidence in World Trade Center Rescue and Recovery Workers: 14 Years of Follow-Up. Li J, Yung J, Qiao B, Takemoto E, Goldfarb DG, Zeig-Owens R, Cone JE, Brackbill RM, Farfel MR, Kahn AR, Schymura MJ, Shapiro MZ, Dasaro CR, Todd AC, Kristjansson D, Prezant DJ, Boffetta P, Hall CB. J Natl Cancer Inst. 2022 Feb 7;114(2):210-219. doi: 10.1093/jnci/djab165. PMID: 34498043; PMCID: PMC8826586.
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post-9/11 cancer. Kehm RD, Li J, Cone JE. Cancer Med. 2024 Aug;13(16):e70071. doi: 10.1002/cam4.70071. PMID: 39190574; PMCID: PMC11348902.
Combining Three Cohorts of World Trade Center Rescue/Recovery Workers for Assessing Cancer Incidence and Mortality. Brackbill RM, Kahn AR, Li J, Zeig-Owens R, Goldfarb DG, Skerker M, Farfel MR, Cone JE, Yung J, Walker DJ, Solomon A, Qiao B, Schymura MJ, Dasaro CR, Kristjansson D, Webber MP, Lucchini RG, Todd AC, Prezant DJ, Boffetta P, Hall CB. Int J Environ Res Public Health. 2021 Feb 3;18(4):1386. doi: 10.3390/ijerph18041386. PMID: 33546187; PMCID: PMC7913216.
Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia. Hantel A, Brunner AM, Plascak JJ, Uno H, Varela JC, Luskin MR, Rebbeck TR, Stone RM, Lathan CS, DeAngelo DJ, Abel GA. J Natl Cancer Inst. 2024 Jul 1;116(7):1178-1184. doi: 10.1093/jnci/djae067. PMID: 38518098; PMCID: PMC11223832.